Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review

被引：0
|
作者：
Simon Taylor
Matthew Lam
Chathyan Pararasa
James EP Brown
Amtul R Carmichael
Helen R Griffiths
机构：
[1] Aston University,Life and Health Sciences
[2] Russells Hall Hospital,undefined
来源：
Cancer Cell International | / 15卷
关键词：
Triple negative breast cancer; Phosphatidylinositol 3-kinase; Metabolism; Glycolysis; Oxidative stress; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer
    Habashy, Hany Onsy
    Rakha, Emad A.
    Aleskandarany, Mohammed
    Ahmed, Mohamed A. H.
    Green, Andrew R.
    Ellis, Ian O.
    Powe, Desmond G.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) : 11 - 21
  • [32] FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer
    Hany Onsy Habashy
    Emad A. Rakha
    Mohammed Aleskandarany
    Mohamed AH Ahmed
    Andrew R. Green
    Ian O. Ellis
    Desmond G. Powe
    Breast Cancer Research and Treatment, 2011, 129 : 11 - 21
  • [33] CHP2 Promotes Cell Proliferation in Breast Cancer via Suppression of FOXO3a
    Zhao, Xiaohui
    Xie, Tian
    Dai, Ting
    Zhao, Wenhui
    Li, Jing
    Xu, Rui
    Jiang, Chao
    Li, Peiqiong
    Deng, Junyao
    Su, Xiaobo
    Ma, Ningfang
    MOLECULAR CANCER RESEARCH, 2018, 16 (10) : 1512 - 1522
  • [34] Activation of FOXO3a reverses 5-Fluorouracil resistance in human breast cancer cells
    Song, Ying
    Lu, Minying
    Qiu, Huisi
    Yin, Jiang
    Luo, Kai
    Zhang, Zhijie
    Jia, Xiaoting
    Zheng, Guopei
    Liu, Hao
    He, Zhimin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2018, 105 (01) : 57 - 62
  • [35] Doxorubicin and Taxol Induce Apoptosis in Breast Cancer Cells by Activating Foxo3a Transcription Factor
    Nestal de Moraes, G.
    Silva, K. L.
    Vasconcelos, F. C.
    Maia, R. C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S129 - S129
  • [36] Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
    McGovern, Ursula B.
    Francis, Richard E.
    Peck, Barrie
    Guest, Stephanie K.
    Wang, Jun
    Myatt, Stephen S.
    Krol, Janna
    Kwok, Jimmy M-M.
    Polychronis, Andreas
    Coombes, R. Charles
    Lam, Eric W-F.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (03) : 582 - 591
  • [37] Foxo3a activation contributes to the synergy of imipridone and radiation in triple-negative breast cancer
    Wang, Shang-Jui
    Schiff, Devora
    Wu, Hao
    Jhawar, Sachin
    Haffty, Bruce G.
    CANCER RESEARCH, 2020, 80 (04)
  • [38] Inhibition of Akt/FOXO3a signaling by constitutively active FOXO3a suppresses growth of follicular thyroid cancer cell lines
    Hong, Zhen-Yu
    Lee, Hyeon Jung
    Shin, Dong Yeob
    Kim, Suk Kyoung
    Seo, MiRan
    Lee, Eun Jig
    CANCER LETTERS, 2012, 314 (01) : 34 - 40
  • [39] MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer (vol 285, pg 17869, 2010)
    Kong, William
    He, Lili
    Coppola, Marc
    Guo, Jianping
    Esposito, Nicole N.
    Coppola, Domenico
    Cheng, Jin Q.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (43) : 22855 - 22855
  • [40] Breast cancer suppression by aplysin is associated with inhibition of PI3K/AKT/FOXO3a pathway
    Zhang, Xinling
    Zhuang, Tingting
    Liang, Zhengyan
    Li, Li
    Xue, Meilan
    Liu, Jia
    Liang, Hui
    ONCOTARGET, 2017, 8 (38) : 63923 - 63934
12345